Peer-reviewed articles

Sharp L, Deady S, Gallagher P, et al. The magnitude and characteristics of the population of cancer survivors: using population-based estimates of cancer prevalence to inform service planning for survivorship care. BMC Cancer. 2014;14(1):767. doi:10.1186/1471-2407-14-767

Burns RM, Leal J, Wolstenhome J, et al. Adopting an Evidence Synthesis Approach for Assessing Cost-Effectiveness of Screening Strategies for Prostate Cancer in Ireland. Value Health. 2014;17(7):A552-553. doi:10.1016/j.jval.2014.08.1807

Burns RM, Leal J, Wolstenhome J, et al. The Burden of Health Care Costs Associated with Prostate Cancer in Ireland. Value Health. 2014;17(7):A627. doi:10.1016/j.jval.2014.08.2237

Hanly P, Maguire R, Hyland P, Sharp L. Carer Perceived Burden as a Predictor of Health-Related Quality of Life: The Case of Colorectal Cancer. Value Health. 2014;17(7):A650. doi:10.1016/j.jval.2014.08.2363

Maguire R, Hanly P, Hyland P, Sharp L. Understanding Caregiver Burden in Colorectal Cancer: What Role Do Patient And Carer Factors Play? Value Health. 2014;17(7):A660. doi:10.1016/j.jval.2014.08.2418

Walsh PM, Byrne J, Kelly M, McDevitt J, Comber H. Socioeconomic Disparity in Survival after Breast Cancer in Ireland: Observational Study. PLoS ONE. 2014;9(11):e111729. doi:10.1371/journal.pone.0111729

Clarke N, Sharp L, Osborne A, Kearney PM. Comparison of uptake of colorectal cancer screening based on faecal immunochemical testing (FIT) in males and females: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. Published online November 6, 2014:cebp.0774.2014. doi:10.1158/1055-9965.EPI-14-0774

Medani S, O’Kelly P, O’Brien KM, Mohan P, Magee C, Conlon P. Bladder cancer in renal allograft recipients: risk factors and outcomes. Transplant Proc. 2014;46(10):3466-3473. doi:10.1016/j.transproceed.2014.06.075

de Camargo Cancela M, Comber H, Sharp L. Which women with breast cancer do, and do not, undergo receptor status testing? A population-based study. Cancer Epidemiology; New York. 2015;39(5):778-782. doi:10.1016/j.canep.2015.08.006

Drummond FJ, Kinnear H, Donnelly C, et al. Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCTure) study. BMJ Open. 2015;5(4):e006851. doi:10.1136/bmjopen-2014-006851

Gavin AT, Drummond FJ, Donnelly C, O’Leary E, Sharp L, Kinnear HR. Patient reported “ever had” and “current” long term physical symptoms following prostate cancer treatments. BJU Int. 2015;116(3):397-406. doi:10.1111/bju.13036

Kiderlen M, Walsh PM, Bastiaannet E, et al. Treatment strategies and survival of older breast cancer patients - an international comparison between the Netherlands and Ireland. PLoS One. 2015;10(2):e0118074. doi:10.1371/journal.pone.0118074

O’Connor M, Costello L, Murphy J, et al. Influences on human papillomavirus (HPV)-related information needs among women having HPV tests for follow-up of abnormal cervical cytology. J Fam Plann Reprod Health Care. 2015;41(2):134-141. doi:10.1136/jfprhc-2013-100750

Drummond FJ, Kinnear H, O’Leary E, Donnelly, Gavin A, Sharp L. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study. J Cancer Surviv. Published online January 7, 2015:1-12. doi:10.1007/s11764-014-0419-6

Drummond FJ, O’Leary E, Sharp L. Lottery ticket was more effective than a prize draw in increasing questionnaire response among cancer survivors. Journal of Clinical Epidemiology. 2015;0(0). doi:10.1016/j.jclinepi.2015.01.013

Traynor C, Conlon P, Phelan PJ, et al. Association of CYP3A variants with kidney transplant outcomes. Ren Fail. Published online February 3, 2015:1-5. doi:10.3109/0886022X.2015.1007013

Pearce AM, Hanly P, Timmons A, et al. Productivity Losses Associated with Head and Neck Cancer Using the Human Capital and Friction Cost Approaches. Appl Health Econ Health Policy. Published online February 19, 2015:1-9. doi:10.1007/s40258-015-0155-8

Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). The Lancet. 2015;385(9972):977-1010. doi:10.1016/S0140-6736(14)62038-9

Dee A, Callinan A, Doherty E, et al. Overweight and obesity on the island of Ireland: an estimation of costs. BMJ Open. 2015;5(3):e006189. doi:10.1136/bmjopen-2014-006189

Barron TI, Murphy LM, Brown C, Bennett K, Visvanathan K, Sharp L. De-novo post-diagnosis aspirin use and mortality in women with stage I-III breast cancer. Cancer Epidemiol Biomarkers Prev. Published online March 19, 2015:cebp.1415.2014. doi:10.1158/1055-9965.EPI-14-1415

O’Leary E, Drummond FJ, Gavin A, Kinnear H, Sharp L. Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate’s egg. Qual Life Res. Published online March 20, 2015:1-12. doi:10.1007/s11136-015-0958-y

O’Brien KM, Dwane F, Kelleher T, Sharp L, Comber H. Interval cancer rates in the Irish national breast screening programme. J Med Screen. Published online April 27, 2015. doi:10.1177/0969141315580386

Hanly P, Céilleachair AÓ, Skally M, O’Neill C, Sharp L. Direct costs of radiotherapy for rectal cancer: a microcosting study. BMC Health Serv Res. 2015;15:184. doi:10.1186/s12913-015-0845-9

Cahir C, Guinan E, Dombrowski SU, Sharp L, Bennett K. Identifying the determinants of adjuvant hormonal therapy medication taking behaviour in women with stages I-III breast cancer: A systematic review and meta-analysis. Patient Educ Couns. Published online May 30, 2015:S0738-3991(15)00234-7. doi:10.1016/j.pec.2015.05.013

Coebergh JW, van den Hurk C, Louwman M, et al. EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees in Europe: From roots to fruits. Eur J Cancer. 2015;51(9):1050-1063. doi:10.1016/j.ejca.2015.02.017